the aid library

LIST OPTIONS

Filter

1905

Sort by:

Direction:

Download (185)

View PDF (246)

Blueprint for a Public Health and Safety Approach to Drug Policy

Tracy Pugh, Julie Netherland, Ruth Finkelstein The New York Academy of Medicine, Drug Policy Alliance (2013) C2

"Some of the problems with our current drug policies stem from the fact that these policies have been largely bifurcated between two different and often contradictory approaches. One treats drug use as a crime that cannot be tolerated and should be punished; the other views addiction as a chronic re... more

Download (179)

View PDF (259)

Neurological disorders public health challenges

World Health Organization WHO WHO (2006) CC

The Global Burden of Disease (GBD) study, a collaborative endeavour of the World Health Organization (WHO), the World Bank and the Harvard School of Public Health, drew the attention of the international health community to the burden of neurological disorders and many other chronic conditions. T... more

Download (172)

View PDF (228)

Haïti : COVID-19 Plan de préparation et de réponse du MSPP, mars 2020

Ministère de la Santè Publique et de la Population Haiti (2020) C1

Le COVID-19 est un nouveau coronavirus, proche de celui du Syndrome Respiratoire Aigu Sévère (SRAS) qui avait été à l’origine d’une épidémie meurtrière en 2003. L’infection par ce nouveau coronavirus se manifeste le plus souvent par une fièvre et des signes respiratoires pouvant se co... more

Download (310)

View PDF (179)

Annuaire des statistiques sanitaires du Togo, Année 2016

République togolaise, Ministère de la Santé et de la Protection Sociale (2017) C1

L’un des principaux défis auxquels fait face le secteur de la santé au Togo est la mise à la disposition des décideurs, des partenaires et du public des données fiables, pertinentes et à temps opportun. Le présent annuaire des statistiques sanitaires a pour objectif, de contribuer à releve... more

Download (263)

View PDF (358)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (572)

View PDF (748)

The Diabetic foot. Prevention and management in India Full Background document (Draft)

National Health Mission; Ministry of Health & Social Welfare India (2016) C1

Standard Treatment Guideline

Download (235)

View PDF (420)

Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy

World Health Organization WHO (2013) C_WHO

New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999

Download (260)

View PDF (395)

Evaluation of the Free Diagnostics Scheme in Andhra Pradesh

Ministry of Health & Family Welfare, India World Health Organization WHO, India (2018) C_WHO

Download (326)

View PDF (670)

Neonatal resuscitation – Understanding challenges & identifying a strategy for implementation in Nepal

Ashish, K.C. Uppsala Universitet (2016) C2

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine | The aim of this study was to explore the risk factors for stillbirth and neonatal death and change in perinatal outcomes after the introduction of helping Babies Breathe Quality Improvement Cycle in Nepal.

Download (470)

View PDF (412)

Dietary Guidelines for Indians

National Instiute for Nutrition, Indian Council for Medical Research (2011) C1

A Manual

Download (443)

View PDF (666)

The Diabetic foot. Prevention and management in India. Quick Reference Guide (Draft)

National Health Mission; Ministry of Health & Social Welfare India (2016) C1

Standard Treatment Guideline

Download (25)

View PDF (25)

Clean Air for Health

Health and Environment Alliance (2023) CC

Air pollution is the top environmental threat to health in Europe. It leads to hundreds of thousands premature deaths per year and billions of Euros in health costs.

Download (94)

View PDF (118)

Sentinel surveillance programme for hospitalised individuals with COVID-19 in South Africa

Jassat, W.; et al. (2020) CC

Download (939)

View PDF (883)

Namibia: Nutrition guidelines for prevention and management of non-communicable diet related disease

Ministry of Health and Social Services (MOHSS) (2013) C1

Download (2944)

View PDF (4972)

Guidelines for Maternity Care in South Africa

Dept. of Health, Republic of South Africa (2015)

4th edition. A manual for clinics, community health centers and district hospitals

Download (702)

View PDF (1273)

WHO/ISH Cardiovascular Risk Prediction Charts for 14 WHO epidemiological sub-regions

World Health Organization WHO (2007) C_WHO

There are two sets of charts. One set (14 charts) can be used in settings where blood cholesterol can be measured. The other set (14 charts) is for settings in which blood cholesterol cannot be measured. Both sets are available in colour and shades of black on a compact disc. Each chart can only be ... more

Download (31)

View PDF (30)

Impact of climate change on non-communicable diseases due to increased ambient air pollution

Breitner-Busch, S.; Mücke, H.; Schneider, A. et al. Journal of Health Monitoring (2023) CC

Background: The impacts of air pollutants on health range from short-term health impairments to hospital admissions and deaths. Climate change is leading to an increase in air pollution.

Download (338)

View PDF (528)

Trends in Maternal Health in Nigeria, 2003-2013

Mallick, Lindsay, Tukur Dahiru, and Kerry L.D. MacQuarrie ICF International (2016) C2

DHS Further Analysis Reports No 102

Download (560)

View PDF (1793)

WHO recommendations on interventions to improve preterm birth outcomes

World Health Organization WHO (2015) C_WHO

The primary audience for this guideline includes health-care professionals who are responsible for developing national and local health-care protocols and policies, as well as managers of maternal and child health programmes and policy-makers in all settings. The guideline will also be useful to tho... more

Download (268)

View PDF (435)

Noncommunicable Diseases (NCD) Country Profiles

World Health Organization (2014) C_WHO